TGen News & Press Releases

TGen launches Vidium Animal Health

Posted Monday September 28, 2020

TGen subsidiary offers genomic diagnostics in support of veterinary oncologists and pet parents treating canine cancer

September 27th Hope Through Hollis Golf Tournament funds TGen childhood brain cancer research

Posted Monday September 21, 2020

Fundraiser at Papago Golf Course remembers 7-year-old Phoenix boy and his valiant fight against DIPG cancer

NCI funds research into why glioblastoma hits males harder than females

Posted Thursday September 17, 2020

TGen technology is key to brain cancer research consortium led by Cleveland Clinic and Case Western Reserve University

TGen and Mayo Clinic researchers ID potential targets for the most-deadly form of pancreatic cancer

Posted Monday September 14, 2020

Multi-year study published today tees-up clinical trials using patient-specific therapies

City of Hope, TGen researchers find link between gut microbiome and cancer treatment outcomes

Posted Wednesday August 19, 2020

Study highlights positive impact of microbial diversity on immunotherapy response and suggests that cancer patients should eat a high-fiber diet with fruits, vegetables and grains with resistant starches

COMBAT study preliminary results show response of 32% in treatment of pancreatic tumors

Posted Tuesday August 11, 2020

TGen and HonorHealth investigators are encouraged with results and hope to show patient benefit in larger studies

Ashion Analytics announces innovative cancer treatment partnership with Elevation Oncology

Posted Wednesday July 22, 2020

Ashion Analytics GEMExTra test detects rare NRG1 gene fusions in patients whose cancer is driven by this genomic alteration for potential matching to a clinical trial

Ashion Analytics receives Medicare coverage for GEM ExTra® assay for patients with advanced solid tumors

Posted Tuesday July 14, 2020

TGen identifies immune effects of a drug in aggressive ovarian cancer that strikes young women

Posted Friday July 10, 2020

SP-2577 could enable the immune system to attack ovarian cancer; clinical trials for patients expected soon

Study led by TGen and City of Hope shows new way of identifying tumor response to immunotherapy

Posted Monday June 22, 2020

Findings could improve personalized medicine for cancer patients

Prev
[1]
2
3
4
5
Next

Media Contact

Newsletter

News Archive

Latest Posts

Useful Links

Contact Us

Stay up-to-date with TGen